Form 4: ClearPoint Neuro CEO Joseph Burnett Disposes of Shares to Cover Tax Obligations
SEC Form 4 Filing
CEO Joseph Burnett disposed of 14,003 shares of ClearPoint Neuro stock on June 10, 2024, to cover tax withholding obligations related to vesting restricted stock.
Summary
- On June 10, 2024, Joseph Michael Burnett, CEO and President of ClearPoint Neuro, Inc., disposed of 14,003 shares of common stock.
- The transaction was executed to satisfy tax withholding obligations associated with the vesting of restricted stock.
- The shares were disposed of at a price of $5.74 per share.
- Following the transaction, Burnett directly owns 249,361 shares of ClearPoint Neuro stock.
Sentiment
Score: 5
Explanation: The document describes a routine transaction (selling shares to cover taxes on vested stock). It's neutral in sentiment as it doesn't indicate positive or negative performance for the company.
Industry Context
This type of transaction is common for executives who receive stock as part of their compensation. Selling shares to cover tax obligations upon vesting is a standard practice.
Stakeholder Impact
- The disposal of shares by the CEO could have a minor impact on shareholders, but it is primarily related to tax obligations and not necessarily indicative of the CEO's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 06/10/2024 | Date of the transaction where 14,003 shares were disposed of. |
| 06/11/2024 | Date of signature on the SEC Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.